Table 2 Demographic and clinicopathologic characteristics of the study population
Factor | Number of patients ( N =101) |
|---|---|
Age | |
 50–59 | 35 (35%) |
 60–69 | 50 (49%) |
 70–75 | 16 (16%) |
Tumour size (mm) | |
 <20 | 48 (48%) |
 20–49 | 46 (46%) |
 ⩾50 | 7 (7%) |
Tumour grade | |
 1 | 15 (15%) |
 2 | 62 (61%) |
 3 | 24 (24%) |
Axillary nodal stage | |
 N0 (negative) | 82 (81%) |
 N1 (1–3 nodes positive) | 19 (19%) |
ER status (H score) | |
 <10 | 1 (1%) |
 10–99 | 8 (8%) |
 100–199 | 49 (49%) |
 ⩾200 | 43 (43%) |
PR status (%) | |
 <5 | 22 (22%) |
 5–39 | 24 (24%) |
 40–79 | 25 (25%) |
 ⩾80 | 30 (30%) |
Ki67% | |
 <10 | 41 (41%) |
 10–19 | 36 (36%) |
 ⩾20 | 24 (24%) |
